About
- Who We Are
Research & Commentary
- Papers
Events
Issues
Projects

khan letter_9-2023

Published by Jeff Cargerman on September 21, 2023

khan-letter_9-2023.pdf

0 Comments

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Name *

Email *

Website

What's on your mind?

Sign Up For Text Message Alerts

^{By adding your phone number, you opt in to receive text messages}

The Market Institute Follow

The Market Institute promotes the work of free market think tanks and associations. We Get Government Out of the Way.

The Market Institute @marketinstitute ·

19h

The U.S. may have copper reserves comparable to Canada and Australia, yet we produce far less.

Why? A permitting system that can delay projects for decades.

Congress should move forward with commonsense reforms that unlock American resources and strengthen economic growth.

Daily Freeman @DailyFreeman

Imagine you had invested in a mine company in 1997, the days of dial-up internet, brick sized portable phones, and “be kind rewind” before returning your rental tape to Blockbuster. https://www.dailyfreeman.com/2026/06/07/charles-sauer-republicans-could-unleash-a-wave-of-growth-and-affordability/?utm_campaign=mrf-twitter-DailyFreeman&utm_source=twitter&utm_medium=social&mrfcid=202606076a18687fa1203f12bd588fb8

Reply on Twitter 2063984925959733540 Retweet on Twitter 2063984925959733540 Like on Twitter 2063984925959733540 1 X 2063984925959733540

Retweet on Twitter The Market Institute Retweeted

Ashley Baker @andashleysays ·

5 Jun

Today, a coalition of 30+ organizations and individuals led by @CmteForJustice sent Congress a letter in support of the NDO Fairness Act, which would ensure nondisclosure orders are subject to judicial review and cannot be used to obtain personal data without notification. 1/x

Reply on Twitter 2062958783366566335 Retweet on Twitter 2062958783366566335 11 Like on Twitter 2062958783366566335 18 X 2062958783366566335

The Market Institute @marketinstitute ·

5 Jun

Exactly right, @sallypipes.

California doesn’t need a government-run drug label. It needs more competition, fewer bureaucratic distortions, and strong patent protections that reward real innovation.

Patients benefit when IP is protected and competition is allowed to work.

Sally Pipes @sallypipes

CalRx's problem isn't patents. Strong IP protections drive medical breakthroughs.

The real mistake is believing government can lower drug prices better than competition. Markets — not bureaucrats — reduce costs.

Reply on Twitter 2062935005400023275 Retweet on Twitter 2062935005400023275 1 Like on Twitter 2062935005400023275 2 X 2062935005400023275

About
Research & Commentary
Events
Issues
Projects